Franklin Resources’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.19M Buy
1,731,854
+1,605,828
+1,274% +$10.1M ﹤0.01% 1359
2026
Q2
$716K Buy
126,026
+7,433
+6% +$36.3K ﹤0.01% 2428
2026
Q1
$509K Buy
118,593
+118,409
+64,353% +$660K ﹤0.01% 2450
2025
Q4
$1.65K Buy
184
+82
+80% +$508 ﹤0.01% 3107
2025
Q3
$377 Sell
102
-108
-51% -$294 ﹤0.01% 3126
2025
Q2
$410 Buy
+210
New +$437 ﹤0.01% 3024
2024
Q3
– Sell
-216,814
Closed -$633K – 2990
2024
Q2
$633K Buy
216,814
+89,131
+70% +$272K ﹤0.01% 2128
2024
Q1
$465K Buy
+127,683
New +$245K ﹤0.01% 2290
2023
Q4
– Sell
-1,470
Closed -$1.97K – 2693
2023
Q3
$1.97K Hold
1,470
– – ﹤0.01% 2651
2023
Q2
$2.65K Sell
1,470
-18,710
-93% -$31.8K ﹤0.01% 2712
2023
Q1
$33.5K Sell
20,180
-16,125
-44% -$32.7K ﹤0.01% 2223
2022
Q4
$69.7K Buy
+36,305
New +$73.5K ﹤0.01% 2173
2022
Q3
– Sell
-537
Closed -$2K – 2372
2022
Q2
$2K Buy
+537
New +$2.34K ﹤0.01% 2349
2021
Q3
– Sell
-800,000
Closed -$7.45M – 2485
2021
Q2
$7.45M Hold
800,000
– – ﹤0.01% 1063
2021
Q1
$8.36M Buy
+800,000
New +$8.94M ﹤0.01% 1015

Other funds holding NUVB

Franklin Resources's NUVB Position: Q3 2026 in Review

Franklin Resources increased its Nuvation Bio (NUVB) stake by 1,274% in Q3 2026, buying an estimated $10.1M and bringing the position to 1,731,854 shares worth $8.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Franklin Resources first reported a position in NUVB in Q1 2021 and has held it in 15 quarters since. The position peaked at $8.36M in Q1 2021. 258 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Franklin Resources held 1,731,854 shares of Nuvation Bio worth $8.19M as of Q3 2026.
  • Franklin Resources bought 1,605,828 Nuvation Bio shares in Q3 2026, an estimated $10.1M.
  • Nuvation Bio made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #1359 holding.
  • Franklin Resources first reported a position in Nuvation Bio in Q1 2021 and has held it in 15 quarters since.
  • Franklin Resources's Nuvation Bio position peaked at $8.36M in Q1 2021.
  • 258 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.